NCT05396612View on ClinicalTrials.gov

Role of the Immune Environment in Response to Therapy in Breast Cancer

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

October 3, 2022

Primary Completion Date

December 31, 2032

Study Completion Date

December 31, 2032

Conditions
Breast CancerER Positive Breast CancerHER2-negative Breast CancerTNBC - Triple-Negative Breast Cancer
Interventions
OTHER

Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.

Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.

Trial Locations (1)

19104

RECRUITING

Abramson Cancer Center, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER